STOCK EXCHANGE ANNOUNCEMENT
3 March 2010
ROLLS-ROYCE GROUP PLC
Rolls-Royce Group plc announces that on 1st March 2010 ordinary shares in the
Company (Shares) were awarded at a price of 537.20 pence per share to Executive
Directors and other Persons Discharging Managerial Responsibility ("PDMRs")
under the terms of the Annual Performance Related Award Deferred Share plan
(APRA) as follows:-
Directors No of Shares
Sir John Rose 29,785
James Guyette 16,272
Andrew Shilston 16,798
Colin Smith 12,480
Mike Terrett 15,555
PDMR's
Tom Brown 10,117
Miles Cowdry 6,265
Dr Michael Haidinger 8,112
Lawrence Haynes 10,207
Mark King 8,001
Daniel Korte 4,310
Alain Michaelis 10,580
Dr Michael Orris 7,885
John Paterson 17,768
Tim Rayner 9,111
Antony Wood 10,133
The Plan awards deferred shares based on Company performance and the Shares
will be transferred to the Executive Directors and PDMR's from the Rolls-Royce
Group 2008 Employee Share Trust in two years time, provided that they remain an
employee of a Rolls-Royce group company.
For further information, please contact:-
Paul Davies - Deputy Company Secretary +44 (0)1332 245878
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.